Growth Metrics

Globus Medical (GMED) Return on Equity (2016 - 2025)

Globus Medical (GMED) has disclosed Return on Equity for 13 consecutive years, with 0.1% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 7.0% year-over-year to 0.1%, compared with a TTM value of 0.1% through Sep 2025, up 7.0%, and an annual FY2024 reading of 0.03%, down 2.0% over the prior year.
  • Return on Equity was 0.1% for Q3 2025 at Globus Medical, up from 0.09% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.11% in Q2 2021 and bottomed at 0.03% in Q4 2022.
  • Average Return on Equity over 5 years is 0.05%, with a median of 0.04% recorded in 2025.
  • The sharpest move saw Return on Equity dropped -12bps in 2022, then rose 7bps in 2025.
  • Year by year, Return on Equity stood at 0.09% in 2021, then plummeted by -137bps to 0.03% in 2022, then skyrocketed by 195bps to 0.03% in 2023, then fell by -17bps to 0.02% in 2024, then soared by 290bps to 0.1% in 2025.
  • Business Quant data shows Return on Equity for GMED at 0.1% in Q3 2025, 0.09% in Q2 2025, and 0.04% in Q1 2025.